<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD000134" GROUP_ID="PREG" ID="879499081020094321" MERGED_FROM="" MODIFIED="2012-01-18 10:14:48 +0100" MODIFIED_BY="Denise Atherton" REVIEW_NO="0031" REVMAN_SUB_VERSION="5.0.22" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="9.0">
<COVER_SHEET MODIFIED="2012-01-18 10:14:48 +0100" MODIFIED_BY="Denise Atherton">
<TITLE>Maternal hydration for increasing amniotic fluid volume in oligohydramnios and normal amniotic fluid volume</TITLE>
<CONTACT MODIFIED="2012-01-18 10:14:48 +0100" MODIFIED_BY="Denise Atherton"><PERSON ID="76315EC182E26AA201AA8B424157761B" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Natalia</FIRST_NAME><LAST_NAME>Novikova</LAST_NAME><EMAIL_1>novikovanatalia@gmail.com</EMAIL_1><MOBILE_PHONE>+27796807821</MOBILE_PHONE><ADDRESS><DEPARTMENT>Department of Obstetrics and Gynaecology, East London Hospital Complex</DEPARTMENT><ORGANISATION>Walter Sisulu University</ORGANISATION><ADDRESS_1>Private Bag X9047</ADDRESS_1><CITY>East London</CITY><ZIP>5200</ZIP><COUNTRY CODE="ZA">South Africa</COUNTRY><PHONE_1>+27796807821</PHONE_1><FAX_1>+27865418347</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2012-01-18 10:14:48 +0100" MODIFIED_BY="Denise Atherton"><PERSON ID="15917" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>G Justus</FIRST_NAME><LAST_NAME>Hofmeyr</LAST_NAME><POSITION>Director/Hon. Professor, Effective Care Research Unit</POSITION><EMAIL_1>justhof@gmail.com</EMAIL_1><ADDRESS><DEPARTMENT>Department of Obstetrics and Gynaecology, East London Hospital Complex</DEPARTMENT><ORGANISATION>University of the Witwatersrand, University of Fort Hare, Eastern Cape Department of Health</ORGANISATION><ADDRESS_1>Frere and Cecilia Makiwane Hospitals</ADDRESS_1><ADDRESS_2>Private Bag X 9047</ADDRESS_2><CITY>East London</CITY><ZIP>5200</ZIP><REGION>Eastern Cape</REGION><COUNTRY CODE="ZA">South Africa</COUNTRY><PHONE_1>+27 43 7092483</PHONE_1><PHONE_2>+27 83 2809402</PHONE_2><FAX_1>+27 43 7092483</FAX_1></ADDRESS></PERSON><PERSON ID="15905" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>A Metin</FIRST_NAME><LAST_NAME>Gülmezoglu</LAST_NAME><POSITION>Scientist</POSITION><EMAIL_1>gulmezoglum@who.int</EMAIL_1><URL>http://www.who.int/reproductive-health/rhl/index.html</URL><ADDRESS><DEPARTMENT>UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, Department of Reproductive Health and Research</DEPARTMENT><ORGANISATION>World Health Organization</ORGANISATION><ADDRESS_1>20 Avenue Appia</ADDRESS_1><CITY>Geneva</CITY><ZIP>1211</ZIP><COUNTRY CODE="CH">Switzerland</COUNTRY><PHONE_1>+41 22 7913417</PHONE_1><FAX_1>+41 22 7914171</FAX_1></ADDRESS></PERSON><PERSON ID="76315EC182E26AA201AA8B424157761B" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Natalia</FIRST_NAME><LAST_NAME>Novikova</LAST_NAME><EMAIL_1>novikovanatalia@gmail.com</EMAIL_1><MOBILE_PHONE>+27796807821</MOBILE_PHONE><ADDRESS><DEPARTMENT>Department of Obstetrics and Gynaecology, East London Hospital Complex</DEPARTMENT><ORGANISATION>Walter Sisulu University</ORGANISATION><ADDRESS_1>Private Bag X9047</ADDRESS_1><CITY>East London</CITY><ZIP>5200</ZIP><COUNTRY CODE="ZA">South Africa</COUNTRY><PHONE_1>+27796807821</PHONE_1><FAX_1>+27865418347</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2009-11-09 12:35:32 +0000" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="1" MONTH="10" YEAR="2009"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="29" MONTH="6" YEAR="2009"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="31" MONTH="12" YEAR="2011"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="1" YEAR="1995"/>
<REVIEW_PUBLISHED ISSUE="1" YEAR="1995"/>
<LAST_CITATION_ISSUE ISSUE="1" YEAR="2002"/>
</DATES>
<WHATS_NEW MODIFIED="2012-01-18 10:14:48 +0100" MODIFIED_BY="Denise Atherton" NOTES="&lt;p&gt;Please update What's new as appropriate.&lt;/p&gt;" NOTES_MODIFIED="2009-11-10 13:46:55 +0000" NOTES_MODIFIED_BY="[Empty name]"><WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2012-01-18 10:14:48 +0100" MODIFIED_BY="Denise Atherton"><DATE DAY="18" MONTH="1" YEAR="2012"/><DESCRIPTION><P>Contact details updated.</P></DESCRIPTION></WHATS_NEW_ENTRY>

</WHATS_NEW>
<HISTORY MODIFIED="2012-01-18 10:14:48 +0100" MODIFIED_BY="Denise Atherton"><WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2012-01-18 10:14:48 +0100" MODIFIED_BY="Denise Atherton">
<DATE DAY="1" MONTH="10" YEAR="2009"/>
<DESCRIPTION>
<P>Search updated. Three trial reports added to <LINK TAG="EXCLUDED_STUDIES" TYPE="SECTION">Excluded studies</LINK> (<LINK REF="STD-Lorzadeh-2005" TYPE="STUDY">Lorzadeh 2005</LINK>; <LINK REF="STD-Malhotra-2002" TYPE="STUDY">Malhotra 2002</LINK>; <LINK REF="STD-Trivedi-2005" TYPE="STUDY">Trivedi 2005</LINK>). One trial (<LINK REF="STD-Yan_x002d_Rosenberg-2007" TYPE="STUDY">Yan-Rosenberg 2007</LINK>) (two reports) added to <LINK TAG="INCLUDED_STUDIES" TYPE="SECTION">Included studies</LINK> in this updated review.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2009-06-29 21:20:49 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="18" MONTH="9" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-10-30 14:06:50 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="27" MONTH="1" YEAR="2004"/>
<DESCRIPTION>
<P> Search rerun but no new trials identified.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-10-30 14:06:41 +0000" MODIFIED_BY="[Empty name]">
<DATE DAY="1" MONTH="9" YEAR="2001"/>
<DESCRIPTION>
<P>Repeat literature search revealed one trial of oral hydration for oligohydramnios (<LINK REF="STD-Deka-2001" TYPE="STUDY">Deka 2001</LINK>), which was excluded because it was not described as a randomised trial.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT>
<INTERNAL_SOURCES>
<SOURCE>
<NAME>University of the Witwatersrand</NAME>
<COUNTRY CODE="ZA">South Africa</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>The Harold Katz Fund, University of the Witwatersrand</NAME>
<COUNTRY CODE="ZA">South Africa</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE>
<NAME>HRP-UNDP/UNFPA/WHO/WORLD BANK Special Programme in Human Reproduction, Geneva</NAME>
<COUNTRY CODE="CH">Switzerland</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES>
<SOURCE>
<NAME>South African Medical Research Council</NAME>
<COUNTRY CODE="ZA">South Africa</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2009-11-10 15:06:55 +0000" MODIFIED_BY="Sonja L  Henderson">
<SUMMARY MODIFIED="2009-11-10 15:06:28 +0000" MODIFIED_BY="Sonja L  Henderson">
<TITLE MODIFIED="2008-09-18 10:45:54 +0100" MODIFIED_BY="[Empty name]">Maternal hydration for increasing amniotic fluid volume in oligohydramnios and normal amniotic fluid volume</TITLE>
<SUMMARY_BODY MODIFIED="2009-11-10 15:06:28 +0000" MODIFIED_BY="Sonja L  Henderson">
<P>Pregnant women with too little fluid surrounding their babies can increase this by consuming liquid, although it is not known whether this improves outcomes.</P>
<P>Oligohydramnios is where there is too little fluid surrounding the baby in the womb (uterus). This may occur because the baby is not thriving properly. It may cause the baby to be unable to turn into the head down position for the birth, or compression of the baby's umbilical cord. The review of four trials (122 women) found that women who drank extra water (usually two litres over two hours) or had fluid dripped directly into their bloodstream (both forms of maternal hydration) increased the volume of the fluid surrounding the baby. However, it is not clear whether this is better for the baby or not. More research is needed.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2009-11-09 12:17:04 +0000" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND>
<P>Oligohydramnios (reduced amniotic fluid) may be responsible for malpresentation problems, umbilical cord compression, concentration of meconium in the liquor, and difficult or failed external cephalic version. Simple maternal hydration has been suggested as a way of increasing amniotic fluid volume in order to reduce some of these problems. </P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES>
<P>The objective of this review was to assess the effects of maternal hydration on amniotic fluid volume and measures of pregnancy outcome.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2009-11-04 12:51:07 +0000" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (June 2009).</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA>
<P>Randomised trials comparing maternal hydration with no hydration in pregnant women with reduced or normal amniotic fluid volume.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2009-06-30 09:50:52 +0100" MODIFIED_BY="Sonja L  Henderson">
<P>Eligibility and trial quality were assessed by both review authors.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2009-11-09 12:16:27 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;To be updated when new trials assessed.&lt;/p&gt;" NOTES_MODIFIED="2009-11-09 12:16:27 +0000" NOTES_MODIFIED_BY="[Empty name]">
<P>Four studies of 122 women were included. The women were asked to drink two litres of water before having a repeat ultrasound examination. Maternal hydration in women with and without oligohydramnios was associated with an increase in amniotic volume (mean difference (MD) for women with oligohydramnios 2.01, 95% confidence interval (CI) 1.43 to 2.60; and MD for women with normal amniotic fluid volume 4.50, 95% CI 2.92 to 6.08). Intravenous hypotonic hydration in women with oligohydramnios was associated with an increase in amniotic fluid volume (MD 1.35, 95% CI 0.61 to 2.10). Isotonic intravenous hydration had no measurable effect. No clinically important outcomes were assessed in any of the trials.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2009-11-09 12:17:04 +0000" MODIFIED_BY="[Empty name]">
<P>Simple maternal hydration appears to increase amniotic fluid volume and may be beneficial in the management of oligohydramnios and prevention of oligohydramnios during labour or prior to external cephalic version. Controlled trials are needed to assess the clinical benefits and possible risks of maternal hydration for specific clinical purposes.<BR/>
</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2009-11-10 15:06:55 +0000" MODIFIED_BY="Sonja L  Henderson">
<BACKGROUND MODIFIED="2009-11-09 12:18:06 +0000" MODIFIED_BY="[Empty name]">
<P>Oligohydramnios (reduced amount of fluid surrounding the baby) may be caused by problems such as placental insufficiency, fetal urinary tract anomalies and chronic amniotic fluid leakage. Irrespective of the cause, oligohydramnios may be responsible for problems such as malpresentation (particularly breech presentation), umbilical cord compression (<LINK REF="REF-Gabbe-1976" TYPE="REFERENCE">Gabbe 1976</LINK>), concentration of meconium in the liquor, difficult or failed external cephalic version (manipulating the baby from breech presentation to cephalic (head first) presentation) (<LINK REF="REF-Benifla-1995" TYPE="REFERENCE">Benifla 1995</LINK>), difficult ultrasound visualisation, and if extreme and early in pregnancy, impaired fetal lung development (pulmonary hypoplasia). Pulmonary hypoplasia, if severe, is usually fatal. Umbilical cord compression during labour may lead to fetal heart rate decelerations and an increased chance of caesarean section, which is reduced by infusing additional fluid into the uterus through a catheter inserted through the cervix (amnioinfusion) (<LINK REF="REF-Hofmeyr-1998" TYPE="REFERENCE">Hofmeyr 1998</LINK>). Artificial augmentation of amniotic fluid volume by amnioinfusion in labour has been shown to be effective in a number of situations (<LINK REF="REF-Hofmeyr-1996a" TYPE="REFERENCE">Hofmeyr 1996a</LINK>; <LINK REF="REF-Hofmeyr-1998" TYPE="REFERENCE">Hofmeyr 1998</LINK>; <LINK REF="REF-Hofmeyr-2002" TYPE="REFERENCE">Hofmeyr 2002</LINK>; <LINK REF="REF-Hofmeyr-1996b" TYPE="REFERENCE">Hofmeyr 1996b</LINK>; <LINK REF="REF-Hofmeyr-2001d" TYPE="REFERENCE">Hofmeyr 2001d</LINK>). Transabdominal amnioinfusion has been suggested during pregnancy to improve ultrasound visualisation in oligohydramnios, to correct extreme oligohydramnios to reduce the risk to fetal lung development, and to facilitate external cephalic version (<LINK REF="REF-Benifla-1995" TYPE="REFERENCE">Benifla 1995</LINK>; <LINK REF="REF-Fisk-1991" TYPE="REFERENCE">Fisk 1991</LINK>). Maternal hydration may theoretically increase amniotic fluid volume by causing fetal diuresis. An effective, non-invasive method of increasing amniotic fluid volume may have several applications in obstetric practice. Most of these would relate to oligohydramnios, but increased volume in women with normal amniotic fluid might also be useful to facilitate external cephalic version.</P>
</BACKGROUND>
<OBJECTIVES MODIFIED="2009-11-09 12:18:23 +0000" MODIFIED_BY="[Empty name]">
<P>To assess the effects of maternal hydration on amniotic fluid volume and fetal well being.</P>
</OBJECTIVES>
<METHODS MODIFIED="2009-11-10 13:49:28 +0000" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2009-11-09 12:18:40 +0000" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES>
<P>Clinical trials comparing the effect of maternal hydration, with a control group (no hydration); random allocation to treatment and control groups, with adequate allocation concealment; violations of allocated management and exclusions after allocation not sufficient to materially affect outcomes.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>Pregnant women with oligohydramnios or normal amniotic fluid volume.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS>
<P>Maternal hydration (oral or intravenous), compared with no hydration.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2009-11-09 12:18:40 +0000" MODIFIED_BY="[Empty name]">
<P>Amniotic fluid volume increase, fetal parameters such as fetal heart rate decelerations, obstetric interventions, perinatal outcomes, maternal assessment of therapy (<I>see</I> table of comparisons).</P>
<P>Outcomes included if reasonable measures taken to minimise observer bias; missing data insufficient to materially influence conclusions; data available for analysis according to original allocation, irrespective of protocol violations; data available in a format suitable for analysis.</P>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2009-11-04 12:51:32 +0000" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2009-11-04 12:51:32 +0000" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register by contacting the Trials Search Co-ordinator (June 2009).</P>
<P>The Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register is maintained by the Trials Search Co-ordinator and contains trials identified from: </P>
<OL>
<LI>quarterly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</LI>
<LI>weekly searches of MEDLINE;</LI>
<LI>handsearches of 30 journals and the proceedings of major conferences;</LI>
<LI>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts. </LI>
</OL>
<P>Details of the search strategies for CENTRAL and MEDLINE, the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service can be found in the &#8216;Specialized Register&#8217; section within the editorial information about the <A HREF="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/preg/frame.html">Cochrane Pregnancy and Childbirth Group</A>. </P>
<P>Trials identified through the searching activities described above are each assigned to a review topic (or topics). The Trials Search Co-ordinator searches the register for each review using the topic list rather than keywords.  </P>
<P>We did not apply any language restrictions.</P>
</ELECTRONIC_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2009-11-10 13:49:28 +0000" MODIFIED_BY="[Empty name]">
<P>For the methods used when assessing the trials identified in the previous version of this review, <I>see </I>
<LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>.</P>
<P>For this update, we used the following methods when assessing the trials identified by the updated search (<LINK REF="STD-Lorzadeh-2005" TYPE="STUDY">Lorzadeh 2005</LINK>; <LINK REF="STD-Malhotra-2002" TYPE="STUDY">Malhotra 2002</LINK>; <LINK REF="STD-Trivedi-2005" TYPE="STUDY">Trivedi 2005</LINK>; <LINK REF="STD-Yan_x002d_Rosenberg-2007" TYPE="STUDY">Yan-Rosenberg 2007</LINK>).</P>
<STUDY_SELECTION MODIFIED="2009-11-09 12:21:06 +0000" MODIFIED_BY="[Empty name]">
<P>Two review authors independently assessed for inclusion all the potential studies we identified as a result of the search strategy. We would resolve any disagreement through discussion or, if required, by consulting the relevant editor.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2009-09-27 20:02:55 +0100" MODIFIED_BY="[Empty name]">
<P>We designed a form to extract data. For eligible studies,<I> two</I> review authors extracted the data using the agreed form. We would resolve discrepancies through discussion or, if required, by consulting the relevant editor. Data were entered into Review Manager software (<LINK REF="REF-RevMan-2008" TYPE="REFERENCE">RevMan 2008</LINK>) and checked for accuracy.</P>
<P>When information regarding any of the above was unclear, we attempted to contact authors of the original reports to provide further details.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2009-11-09 12:21:58 +0000" MODIFIED_BY="[Empty name]">
<P>Two review authors independently assessed risk of bias for each study using the criteria outlined in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>). Any disagreement would be resolved by discussion or by involving the relevant editor.</P>
<SUBSECTION>
<HEADING LEVEL="4">(1) Sequence generation (checking for possible selection bias)</HEADING>
<P>We described for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups.</P>
<P>We assessed the method as:</P>
<UL>
<LI>adequate (any truly random process, e.g. random number table; computer random number generator);</LI>
<LI>inadequate (any non random process, e.g. odd or even date of birth; hospital or clinic record number); or</LI>
<LI>unclear.   </LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4"> (2) Allocation concealment (checking for possible selection bias)</HEADING>
<P>We described for each included study the method used to conceal the allocation sequence in sufficient detail and determine whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>adequate (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes);</LI>
<LI>inadequate (open random allocation; unsealed or non-opaque envelopes, alternation; date of birth);</LI>
<LI>unclear.   </LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(3) Blinding (checking for possible performance bias)</HEADING>
<P>We described for each included study the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. Studies were judged at low risk of bias if they were blinded, or if we judged that the lack of blinding could not have affected the results. Blinding was assessed separately for different outcomes or classes of outcomes.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>adequate, inadequate or unclear for participants;</LI>
<LI>adequate, inadequate or unclear for personnel;</LI>
<LI>adequate, inadequate or unclear for outcome assessors</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(4) Incomplete outcome data (checking for possible attrition bias through withdrawals, dropouts, protocol deviations)</HEADING>
<P>We described for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We stated whether attrition and exclusions were reported, the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes.  Where sufficient information was reported, or could be supplied by the trial authors, we re-included missing data in the analyses which we undertook. We assessed methods as:</P>
<UL>
<LI>adequate (&lt; 10% loss);</LI>
<LI>inadequate:</LI>
<LI>unclear</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(5) Selective reporting bias</HEADING>
<P>We described for each included study how we investigated the possibility of selective outcome reporting bias and what we found.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>adequate (where it was clear that all of the study&#8217;s pre-specified outcomes and all expected outcomes of interest to the review had been reported);</LI>
<LI>inadequate (where not all the study&#8217;s pre-specified outcomes had been reported; one or more reported primary outcomes were not pre-specified; outcomes of interest were reported incompletely and so could not be used; study failed to include results of a key outcome that would have been expected to have been reported);</LI>
<LI>unclear.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(6) Other sources of bias</HEADING>
<P>We described for each included study any important concerns we had about other possible sources of bias.</P>
<P>We assessed whether each study was free of other problems that could put it at risk of bias:</P>
<UL>
<LI>yes;</LI>
<LI>no;</LI>
<LI>unclear.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(7) Overall risk of bias</HEADING>
<P>We made explicit judgements about whether studies were at high risk of bias, according to the criteria given in the Handbook (<LINK REF="REF-Higgins-2008" TYPE="REFERENCE">Higgins 2008</LINK>). With reference to (1) to (6) above, we assessed the likely magnitude and direction of the bias and whether we considered it is likely to impact on the findings.  We would explore the impact of the level of bias through undertaking sensitivity analyses - <I>see </I> <LINK TAG="SENSITIVITY_ANALYSIS" TYPE="SECTION">Sensitivity analysis</LINK>. </P>
</SUBSECTION>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2009-09-27 17:29:16 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">
<I>Dichotomous data</I>
</HEADING>
<P>For dichotomous data, we presented results as summary risk ratio with 95% confidence intervals.<I> </I>
</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">
<I>Continuous data</I>
</HEADING>
<P>For continuous data, we used the mean difference if outcomes are measured in the same way between trials. We used the standardised mean difference to combine trials that measure the same outcome, but use different methods. <B> </B>
</P>
</SUBSECTION>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2009-11-09 12:22:44 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Cluster-randomised trials</HEADING>
<P>Cluster-randomised trials and crossover trials were considered unlikely to be relevant to this review<B> </B>
</P>
</SUBSECTION>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2009-09-27 17:32:16 +0100" MODIFIED_BY="[Empty name]">
<P>For included studies, levels of attrition were noted. The impact of including studies with high levels of missing data in the overall assessment of treatment effect were explored by using sensitivity analysis.</P>
<P>For all outcomes analyses were carried out, as far as possible, on an intention-to-treat basis, i.e. we attempted to include all participants randomised to each group in the analyses. The denominator for each outcome in each trial was the number randomised minus any participants whose outcomes were known to be missing.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2009-11-09 12:22:57 +0000" MODIFIED_BY="[Empty name]">
<P>We used the I² statistic to measure heterogeneity among the trials in each analysis. If we identified substantial heterogeneity (I² &gt; 50%) we would explore it by pre-specified subgroup analysis.<B> </B>
</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2009-09-27 17:34:59 +0100" MODIFIED_BY="[Empty name]">
<P>Where we suspected reporting bias (<I>see</I> &#8216;Selective reporting bias&#8217; above), we would attempt to contact study authors asking them to provide missing outcome data. Where this was not possible, and the missing data were thought to introduce serious bias, the impact of including such studies in the overall assessment of results would be explored by a sensitivity analysis<B>. </B>
</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2009-09-27 17:36:12 +0100" MODIFIED_BY="[Empty name]">
<P>We carried out statistical analysis using the Review Manager software (<LINK REF="REF-RevMan-2008" TYPE="REFERENCE">RevMan 2008</LINK>). We used fixed-effect inverse variance meta-analysis for combining data where trials were examining the same intervention, and the trials&#8217; populations and methods are judged sufficiently similar. Where we suspected clinical or methodological heterogeneity between studies sufficient to suggest that treatment effects may differ between trials we would use random-effects meta-analysis.</P>
<P>If substantial heterogeneity was identified in a fixed-effect meta-analysis this would be noted and the analysis repeated using a random-effects method.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2009-11-09 12:23:37 +0000" MODIFIED_BY="[Empty name]">
<P>We did not plan to carry out subgroup analyses.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2009-09-27 17:39:11 +0100" MODIFIED_BY="[Empty name]">
<P>We would carry out sensitivity analysis to assess the effect of including trials with greater risk of bias, if there were sufficient trials.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2009-11-10 15:06:55 +0000" MODIFIED_BY="Sonja L  Henderson">
<STUDY_DESCRIPTION MODIFIED="2009-11-10 15:06:55 +0000" MODIFIED_BY="Sonja L  Henderson" NOTES="&lt;p&gt;Does not include results of the new search&lt;/p&gt;" NOTES_MODIFIED="2009-11-10 15:06:55 +0000" NOTES_MODIFIED_BY="Sonja L  Henderson">
<P>
<I>See</I> table of <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>.</P>
<P>Four studies (122 women) met the pre-stated criteria. In studies of women with oligohydramnios (<LINK REF="STD-Doi-1998" TYPE="STUDY">Doi 1998</LINK>; <LINK REF="STD-Kilpatrick-1991" TYPE="STUDY">Kilpatrick 1991</LINK>), women in the treatment group were asked to drink two litres of water over two hours one to four hours before repeat ultrasound examination the next day or they were given hypotonic saline solution (1/2 normal saline) at a rate of 1000 mL per hour over two hours in treatment group and 10 mL per hour in control group and amniotic fluid index was checked an hour later (Yan-Rosenberg 2007). In the study of women with normal amniotic fluid (<LINK REF="STD-Kilpatrick-1993" TYPE="STUDY">Kilpatrick 1993</LINK>), the treatment group were asked to drink two litres of water while the control group were asked to drink 100 ml, and ultrasound examination was repeated four to six hours later.</P>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2009-11-09 12:24:17 +0000" MODIFIED_BY="[Empty name]">
<P>
<I>See</I> table of <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>.</P>
<P>Women with oligohydramnios were allocated 'randomly' to treatment and control groups (<LINK REF="STD-Doi-1998" TYPE="STUDY">Doi 1998</LINK>; <LINK REF="STD-Kilpatrick-1991" TYPE="STUDY">Kilpatrick 1991</LINK>). For random allocation of women with normal amniotic fluid volumes (<LINK REF="STD-Kilpatrick-1993" TYPE="STUDY">Kilpatrick 1993</LINK>) opaque envelopes were used. The studies appeared to be methodologically sound.</P>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2009-11-09 12:26:08 +0000" MODIFIED_BY="[Empty name]">
<P>The amniotic fluid index was significantly increased in the treatment group compared with the control group in both the studies of women with oligohydramnios (two studies, 78 women; mean difference (MD) 2.01, 95% confidence interval (CI) 1.43 to 2.60) (<LINK REF="STD-Doi-1998" TYPE="STUDY">Doi 1998</LINK>; <LINK REF="STD-Kilpatrick-1991" TYPE="STUDY">Kilpatrick 1991</LINK>) and normal amniotic fluid volume (one study, 40 women; MD 4.50, 95% CI 2.92 to 6.08) (<LINK REF="STD-Kilpatrick-1993" TYPE="STUDY">Kilpatrick 1993</LINK>). <LINK REF="STD-Doi-1998" TYPE="STUDY">Doi 1998</LINK> compared intravenous isotonic and hypotonic fluid infusions as well as oral hydration. Hypotonic and isotonic infusions did not increase the amniotic fluid volume at a level similar to that of oral hydration (two trials, 86 women; MD 1.35, 95% CI 0.61 to 2.10). No adverse effects on the mother or infant have been reported in the four studies included in this review.</P>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION>
<P>In view of the many obstetric situations in which reduced amniotic fluid volume may pose problems, particularly for the fetus, the possibility of increasing amniotic fluid volume with a simple, inexpensive method such as maternal hydration may have useful clinical applications. However, clinical outcomes were not assessed in these trials. Drinking two litres of water in a relatively short period of time may be unpleasant and difficult for women too. None of the studies reported any maternal satisfaction information. Perhaps if the mother experiences difficulties hydration can be spread over a longer time.</P>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2009-11-09 12:26:55 +0000" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE>
<P>As the studies reviewed have not assessed clinically relevant outcomes or possible complications, there is no evidence to support the use of maternal hydration in routine practice, except in the framework of further clinical trials designed to address these issues.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2009-11-09 12:26:55 +0000" MODIFIED_BY="[Empty name]">
<P>The studies reviewed have shown in principle that amniotic fluid volume may be increased by maternal hydration. Because maternal hydration is simple and inexpensive, trials to investigate its effectiveness in oligohydramnios in terms of clinically important outcomes such as fetal heart rate decelerations and in the case of extreme oligohydramnios, lung development, and assessing potential dangers such as electrolyte disturbance if used over an extended period, are worthwhile. The use of maternal hydration prior to external cephalic version at term also is worth investigating. In the light of the data reviewed here, the possible negative effect of starvation during labour on amniotic fluid level requires investigation (<LINK REF="REF-Hofmeyr-1999" TYPE="REFERENCE">Hofmeyr 1999</LINK>).</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS>
<P>None.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None known.<BR/>
</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2009-11-09 12:27:17 +0000" MODIFIED_BY="[Empty name]">
<P>GJ Hofmeyr prepared the original version, and is responsible for maintaining the review. AM Gülmezoglu quality-checked and revised the review, and N Novikova prepared the first version of the current update.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2009-09-27 17:43:52 +0100" MODIFIED_BY="[Empty name]">
<P>The original protocol has been updated with current methodology as described above.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES MODIFIED="2009-11-04 12:54:32 +0000" MODIFIED_BY="[Empty name]"/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2009-11-04 13:33:46 +0000" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2009-11-04 13:18:40 +0000" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2009-11-04 13:14:00 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Doi-1998" MODIFIED="2009-11-04 13:11:39 +0000" MODIFIED_BY="[Empty name]" NAME="Doi 1998" YEAR="1998">
<REFERENCE MODIFIED="2009-06-29 20:47:21 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;[9819]&lt;/p&gt;" NOTES_MODIFIED="2009-06-29 20:47:21 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Doi S, Osada H, Itoh K, Ikeda K, Sekiya S, Takehisa T</AU>
<TI>Effect of maternal hydration on oligohydramnios: a comparison of three volume expansion methods [abstract]</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1998</YR>
<VL>178</VL>
<NO>1 Pt 2</NO>
<PG>S156</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-11-04 13:11:39 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;[10163]&lt;/p&gt;" NOTES_MODIFIED="2009-11-04 13:11:39 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Doi S, Osada H, Seki K, Sekiya S</AU>
<TI>Effect of maternal hydration on oligohydramnios: a comparison of three volume expansion methods</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>1998</YR>
<VL>92</VL>
<PG>525-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kilpatrick-1991" MODIFIED="2009-08-05 10:10:45 +0100" MODIFIED_BY="Jill V Hampson" NAME="Kilpatrick 1991" YEAR="1991">
<REFERENCE MODIFIED="2009-08-05 10:10:35 +0100" MODIFIED_BY="Jill V Hampson" NOTES="&lt;p&gt;[6320]&lt;/p&gt;" NOTES_MODIFIED="2009-08-05 10:10:35 +0100" NOTES_MODIFIED_BY="Jill V Hampson" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kilpatrick SJ, Safford K, Pomeroy T, Hoedt L, Scheerer L, Laros RK</AU>
<TI>Maternal hydration affects amniotic fluid index (AFI)</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1991</YR>
<VL>164</VL>
<PG>361</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-08-05 10:10:45 +0100" MODIFIED_BY="Jill V Hampson" NOTES="&lt;p&gt;[10434]&lt;/p&gt;" NOTES_MODIFIED="2009-08-05 10:10:45 +0100" NOTES_MODIFIED_BY="Jill V Hampson" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Kilpatrick SJ, Safford KL, Pomeroy T, Hoedt L, Scheerer L, Laros RK</AU>
<TI>Maternal hydration increases amniotic fluid index</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>1991</YR>
<VL>78</VL>
<PG>1098-102</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kilpatrick-1993" MODIFIED="2009-06-29 20:48:47 +0100" MODIFIED_BY="[Empty name]" NAME="Kilpatrick 1993" YEAR="1993">
<REFERENCE MODIFIED="2009-06-29 20:48:47 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;[7667]&lt;/p&gt;" NOTES_MODIFIED="2009-06-29 20:48:47 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kilpatrick SJ, Safford SJ</AU>
<TI>Maternal hydration increases amniotic fluid index in women with normal amniotic fluid</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>1993</YR>
<VL>81</VL>
<PG>49-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Yan_x002d_Rosenberg-2007" MODIFIED="2009-11-04 13:14:00 +0000" MODIFIED_BY="[Empty name]" NAME="Yan-Rosenberg 2007" YEAR="2007">
<REFERENCE MODIFIED="2009-11-04 13:14:00 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yan-Rosenberg L, Burt B, Bombard AT,Callado-Khoury F, Sharett L, Julliard K, et al</AU>
<TI>A randomized clinical trial comparing the effect of maternal intravenous hydration and placebo on the amniotic fluid index in oligohydramnios</TI>
<SO>Journal of Maternal-Fetal &amp; Neonatal Medicine</SO>
<YR>2007</YR>
<VL>20</VL>
<NO>10</NO>
<PG>715-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2009-11-04 12:53:37 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Yan-Rosenberg, Burt S, Collado-Khoury, Sharet L, Bombard A, Weiner Z</AU>
<TI>Effect of maternal hydration on the AFI in women with oligohydramnios [abstract]</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>2005</YR>
<VL>193</VL>
<NO>6 Suppl</NO>
<PG>S101</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2009-11-04 13:18:40 +0000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Chelmow-1996" NAME="Chelmow 1996" YEAR="1996">
<REFERENCE NOTES="&lt;p&gt;&lt;br&gt;&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chelmow D, Baker ER, Jones L</AU>
<TI>Maternal intravenous hydration and amniotic fluid index in patients with preterm ruptured membranes</TI>
<SO>Journal of the Society for Gynecologic Investigation</SO>
<YR>1996</YR>
<VL>3</VL>
<PG>127-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Deka-2001" MODIFIED="2009-06-29 20:49:44 +0100" MODIFIED_BY="[Empty name]" NAME="Deka 2001" YEAR="2001">
<REFERENCE MODIFIED="2009-06-29 20:49:44 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Deka D, Malhotra B</AU>
<TI>Role of maternal oral hydration in increasing amniotic fluid volume in pregnant women with oligohydramnios</TI>
<SO>International Journal of Gynecology &amp; Obstetrics</SO>
<YR>2001</YR>
<VL>73</VL>
<PG>155-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kerr-1996" MODIFIED="2009-06-29 20:50:20 +0100" MODIFIED_BY="[Empty name]" NAME="Kerr 1996" YEAR="1996">
<REFERENCE MODIFIED="2009-06-29 20:50:20 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;[10124]&lt;/p&gt;" NOTES_MODIFIED="2009-06-29 20:50:20 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kerr J, Borgida AF, Hardardottir H, Calhoun S, Galetta J, Egan JFX</AU>
<TI>Maternal hydration and its effect on the amniotic fluid index [abstract]</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1996</YR>
<VL>174</VL>
<NO>1 Pt 2</NO>
<PG>416</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lorzadeh-2005" MODIFIED="2009-11-04 13:16:19 +0000" MODIFIED_BY="[Empty name]" NAME="Lorzadeh 2005" YEAR="2005">
<REFERENCE MODIFIED="2009-11-04 13:16:19 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lorzadeh N, Najafi S, Parsa M, Kasemirad C.</AU>
<TI>Effect of maternal hydration on amniotic fluid index</TI>
<SO>Ultrasound in Obstetrics &amp; Gynecology</SO>
<YR>2005</YR>
<VL>26</VL>
<NO>4</NO>
<PG>370</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS MODIFIED="2009-09-30 18:19:27 +0100" MODIFIED_BY="[Empty name]"/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Malhotra-2002" MODIFIED="2009-11-04 13:17:08 +0000" MODIFIED_BY="[Empty name]" NAME="Malhotra 2002" YEAR="2002">
<REFERENCE MODIFIED="2009-11-04 13:17:08 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Malhotra B, Deka D</AU>
<TI>Maternal oral hydration with hypotonic solution (water) increases amniotic fluid volume in pregnancy</TI>
<SO>Journal of Obstetrics and Gynecology of India</SO>
<YR>2002</YR>
<VL>52</VL>
<NO>1</NO>
<PG>49-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Trivedi-2005" MODIFIED="2009-11-04 13:18:40 +0000" MODIFIED_BY="[Empty name]" NAME="Trivedi 2005" YEAR="2005">
<REFERENCE MODIFIED="2009-11-04 13:18:40 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Trivedi KK, Trivedi KK</AU>
<TI>Liquid endosperm of coconut consumed orally increases amniotic fluid in oligohydramnios</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>2005</YR>
<VL>105</VL>
<NO>4 Suppl</NO>
<PG>35S</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2009-09-30 18:22:15 +0100" MODIFIED_BY="[Empty name]"/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2009-11-04 13:33:46 +0000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2009-11-04 13:33:46 +0000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Benifla-1995" NAME="Benifla 1995" TYPE="JOURNAL_ARTICLE">
<AU>Benifla JL, Goffinet F, Bascou V, Darai E, Proust A, Madelenat P</AU>
<TI>Transabdominal amnio-infusion facilitates external version manouver after initial failure (translation)</TI>
<SO>Journal de Gynecologie, Obstetrique et Biologie de la Reproduction (Paris)</SO>
<YR>1995</YR>
<VL>24</VL>
<PG>319-22</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Clarke-2001" NAME="Clarke 2001" TYPE="OTHER">
<AU>Clarke M, Oxman AD, editors</AU>
<TI>Cochrane Reviewers' Handbook 4.1 [updated December 2000]</TI>
<SO>In: The Cochrane Library [database on CDROM]. The Cochrane Collaboration. Oxford: Update Software; 2000, issue 4</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fisk-1991" MODIFIED="2009-08-05 09:59:24 +0100" MODIFIED_BY="Jill V Hampson" NAME="Fisk 1991" TYPE="JOURNAL_ARTICLE">
<AU>Fisk NM, Ronderos-Dumit D, Soliani A, Nicolini U, Vaughan J, Rodeck CH</AU>
<TI>Diagnostic and therapeutic transabdominal amnioinfusion in oligohydramnios</TI>
<SO>Obstetrics &amp; Gynecology</SO>
<YR>1991</YR>
<VL>78</VL>
<NO>2</NO>
<PG>270-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Gabbe-1976" NAME="Gabbe 1976" TYPE="JOURNAL_ARTICLE">
<AU>Gabbe SG, Ettinger BB, Freeman RK, Martin CB</AU>
<TI>Umbilical cord compression associated with amniotomy: laboratory observations</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1976</YR>
<VL>126</VL>
<PG>353-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2008" MODIFIED="2009-08-05 10:00:54 +0100" MODIFIED_BY="Jill V Hampson" NAME="Higgins 2008" TYPE="OTHER">
<AU>Higgins JPT, Green S, editors</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 2008</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hofmeyr-1996a" MODIFIED="2009-11-04 13:27:50 +0000" MODIFIED_BY="[Empty name]" NAME="Hofmeyr 1996a" TYPE="JOURNAL_ARTICLE">
<AU>Hofmeyr GJ, Gulmezoglu AM, Nikodem VC, De Jager M</AU>
<TI>Amnioinfusion</TI>
<SO>European Journal of Obstetrics &amp; Gynecology and Reproductive Biology</SO>
<YR>1996</YR>
<VL>64</VL>
<PG>159-65</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hofmeyr-1996b" MODIFIED="2009-11-04 13:27:42 +0000" MODIFIED_BY="[Empty name]" NAME="Hofmeyr 1996b" TYPE="COCHRANE_REVIEW">
<AU>Hofmeyr GJ</AU>
<TI>Prophylactic versus therapeutic amnioinfusion for oligohydramnios in labour</TI>
<TO>.</TO>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>1996</YR>
<NO>1</NO>
<PB>Update Software</PB>
<CY>Oxford</CY>
<IDENTIFIERS MODIFIED="2009-11-04 13:27:12 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-11-04 13:27:12 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD000176"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hofmeyr-1998" MODIFIED="2009-11-04 13:24:09 +0000" MODIFIED_BY="[Empty name]" NAME="Hofmeyr 1998" TYPE="COCHRANE_REVIEW">
<AU>Hofmeyr GJ</AU>
<TI>Amnioinfusion for potential or suspected umbilical cord compression in labour.</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>1998</YR>
<NO>1</NO>
<PB>Update Software</PB>
<CY>Oxford</CY>
<IDENTIFIERS MODIFIED="2009-11-04 13:24:03 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-11-04 13:24:03 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD000013"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hofmeyr-1999" NAME="Hofmeyr 1999" TYPE="JOURNAL_ARTICLE">
<AU>Hofmeyr GJ, Scott F, Schalkwyk C, Nikodem VC</AU>
<TI>Hydration during labour--a recipe</TI>
<SO>South African Medical Journal</SO>
<YR>1999</YR>
<VL>89</VL>
<PG>102-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hofmeyr-2001d" MODIFIED="2009-08-05 10:18:16 +0100" MODIFIED_BY="Jill V Hampson" NAME="Hofmeyr 2001d" TYPE="COCHRANE_REVIEW">
<AU>Hofmeyr GJ</AU>
<TI>Amnioinfusion for preterm rupture of membranes</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>1998</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2009-08-05 10:18:07 +0100" MODIFIED_BY="Jill V Hampson">
<IDENTIFIER MODIFIED="2009-08-05 10:18:07 +0100" MODIFIED_BY="Jill V Hampson" TYPE="DOI" VALUE="10.1002/14651858.CD000942"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Hofmeyr-2002" MODIFIED="2009-11-04 13:25:58 +0000" MODIFIED_BY="[Empty name]" NAME="Hofmeyr 2002" TYPE="COCHRANE_REVIEW">
<AU>Hofmeyr GJ</AU>
<TI>Amnioinfusion for meconium-stained liquor in labour</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2002</YR>
<NO>1</NO>
<PB>Update Software</PB>
<CY>Oxford</CY>
<IDENTIFIERS MODIFIED="2009-11-04 13:25:40 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2009-11-04 13:25:40 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD000014"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2000" NAME="RevMan 2000" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2000</YR>
<EN>4.1 for Windows</EN>
<PB>The Cochrane Collaboration</PB>
<CY>Oxford, England</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2008" MODIFIED="2009-08-05 10:01:02 +0100" MODIFIED_BY="Jill V Hampson" NAME="RevMan 2008" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2008</YR>
<EN>5.0</EN>
<PB>The Cochrane Collaboration</PB>
<CY>Copenhagen, The Nordic Cochrane Centre</CY>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2009-08-05 10:16:59 +0100" MODIFIED_BY="Jill V Hampson">
<REFERENCE ID="REF-Hofmery-2002" MODIFIED="2009-08-05 10:16:59 +0100" MODIFIED_BY="Jill V Hampson" NAME="Hofmery 2002" TYPE="COCHRANE_REVIEW">
<AU>Hofmeyr GJ, Gülmezoglu AM</AU>
<TI>Maternal hydration for increasing amniotic fluid volume in oligohydramnios and normal amniotic fluid volume</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2002</YR>
<NO>1</NO>
<PB>Update Software</PB>
<CY>Oxford</CY>
<IDENTIFIERS MODIFIED="2009-08-05 10:16:57 +0100" MODIFIED_BY="Jill V Hampson">
<IDENTIFIER MODIFIED="2009-08-05 10:16:57 +0100" MODIFIED_BY="Jill V Hampson" TYPE="DOI" VALUE="10.1002/14651858.CD000134"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2009-11-11 10:24:24 +0000" MODIFIED_BY="Sonja L  Henderson">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2009-11-11 10:24:24 +0000" MODIFIED_BY="Sonja L  Henderson" NOTES="&lt;p&gt;Judgements marked as 'unclear' without text in the description will not be published in the Cochrane Library.&lt;/p&gt;" NOTES_MODIFIED="2009-11-11 10:24:24 +0000" NOTES_MODIFIED_BY="Sonja L  Henderson" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2009-11-09 12:27:41 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Doi-1998">
<CHAR_METHODS>
<P>Randomised, sealed envelopes used for allocation. Numbering or sequential opening are not mentioned. Outcome assessments were blinded.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>84 women with low amniotic fluid index and gestational age more than 35 weeks.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-11-09 12:27:41 +0000" MODIFIED_BY="[Empty name]">
<P>Group 1: intravenous infusion of 2 litres of Ringer lactate over 2 hours (isotonic).<BR/>Group 2: intravenous infusion of 2 litres of diluted Ringer lactate over 2 hours (hypotonic).<BR/>Group 3: oral intake of 2 litres of water over 2 hours.<BR/>Group 4: control group.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Change in amniotic fluid index, blood chemistry.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Power calculation reported.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-11-09 12:28:16 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kilpatrick-1991">
<CHAR_METHODS>
<P>Randomised by card selection.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-11-09 12:28:00 +0000" MODIFIED_BY="[Empty name]">
<P>Women with oligohydramnios (amniotic fluid index 2.1-6 cm); no indication for delivery; membranes intact; biophysical profile at least 8/10 or contraction stress test negative (women with amniotic fluid index 5.0 cm or less).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-11-09 12:28:06 +0000" MODIFIED_BY="[Empty name]">
<P>Women asked to drink 2 litres of water 2-4 hours before repeat ultrasound examination on the same or the next day (n = 20), compared with controls, who were asked to drink their normal amount of fluid, and in the last 10 women an extra 100 ml (n = 20).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Change in amniotic fluid index; maternal urine specific gravity.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-11-09 12:28:16 +0000" MODIFIED_BY="[Empty name]">
<P>Observer blinded to group allocation. 1 woman in the hydration group excluded because of indomethacin therapy; 2 in the control group excluded because of drinking at least 2 litres of water, and one because of receiving an intravenous infusion.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-11-09 12:28:39 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kilpatrick-1993">
<CHAR_METHODS>
<P>Allocation using opaque envelopes which were randomly mixed, then numbered consecutively.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-11-09 12:28:27 +0000" MODIFIED_BY="[Empty name]">
<P>Women with normal amniotic fluid volume; no known pregnancy complications; &gt; 28 weeks' gestation; singleton pregnancy; no ruptured membranes.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-11-09 12:28:33 +0000" MODIFIED_BY="[Empty name]">
<P>Women asked to drink 2 litres of water over 2 hours and re-examined 2-5 hours later (n = 20), compared with control group asked to drink 100 ml water (n = 20).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Increase in amniotic fluid volume; maternal urine specific gravity.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-11-09 12:28:39 +0000" MODIFIED_BY="[Empty name]">
<P>Observer blinded to group allocation. There appeared to be no losses to follow up.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2009-11-09 12:29:13 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Yan_x002d_Rosenberg-2007">
<CHAR_METHODS MODIFIED="2009-11-09 12:28:46 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised, double-blinded, placebo-controlled.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2009-11-09 12:29:09 +0000" MODIFIED_BY="[Empty name]">
<P>Women with singleton pregnancy between 37 and 42 weeks of gestation with AFI &lt; 6 with no maternal and no fetal complications.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2009-11-09 12:29:11 +0000" MODIFIED_BY="[Empty name]">
<P>Treatment group - women received IV infusion of 1/2 NS at 1L/h for 2 hours.</P>
<P>Control group - received IV infusion of 1/2 NS at 10 mL/h.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2009-11-09 12:29:13 +0000" MODIFIED_BY="[Empty name]">
<P>AFI was re-assessed by a sonographer at 1 hour after the infusion was stopped.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2009-08-16 14:39:09 +0100" MODIFIED_BY="[Empty name]">
<P>Power calculation done.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>AFI: amniotic fluid index<BR/>IV: intravenous</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2009-11-09 12:33:09 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2009-11-09 12:31:45 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chelmow-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-09 12:31:45 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded because data not available in a format suitable for meta-analysis.</P>
<P>13 non-labouring women at 24-37 weeks' gestation with documented ruptured membranes were 'randomised' to an intravenous fluid bolus with 1 litre of normal saline administered over 30 minutes (n = 6) versus no hydration (n = 7).</P>
<P>All women had baseline AFI measured. The same blinded examiner repeated the examination 90 minutes later. The groups were similar in age, gravidity, parity, time since rupture, gestational age, and baseline AFI. In the hydration group, the AFI increased 5.1 cm (95% CI 2.9 to 7.3) after the fluid bolus. In the no-hydration group, the change was 0.6 cm (95% CI, 1.1 to 2.2). The difference in the change in AFI between groups was 4.5 cm (95% CI, 1.3 to 7.7) (P = .008).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-09 12:32:39 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Deka-2001">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-09 12:32:39 +0000" MODIFIED_BY="[Empty name]">
<P>Excluded because allocation does not appear to have been randomised. 25 women with oligohydramnios (AFI &lt; 8 cm) received oral hydration with 2 l water over 1 hour, and 25 women with oligohydramnios were taken as controls. AFI after hydration increased from a mean value of 6.99, SD 1.62 cm, to 10.48, SD 4.96cm (P &lt; 0.001). In the control group there was a non-significant decrease by 0.42, SD 0.71 cm.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-09 12:32:57 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kerr-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-09 12:32:57 +0000" MODIFIED_BY="[Empty name]">
<P>Published only as an abstract. Data are not presented in a suitable form for analysis. 50 patients with normal AFI undergoing antenatal testing were randomised to a hydration (oral water 1l /1 hour) or control (150 ml water).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-09 12:33:06 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lorzadeh-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-09 12:33:06 +0000" MODIFIED_BY="[Empty name]">
<P>Published only as an abstract. It is unclear whether the study was randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-11-09 12:33:09 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Malhotra-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-11-09 12:33:09 +0000" MODIFIED_BY="[Empty name]">
<P>It is unclear of the study was randomised.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2009-08-16 14:04:29 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Trivedi-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2009-08-16 14:04:29 +0100" MODIFIED_BY="[Empty name]">
<P>Published only abstract. Randomisation not mentioned.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>AFI: amniotic fluid index<BR/>CI: confidence interval<BR/>SD: standard deviation</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2009-09-30 18:22:15 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2009-11-11 10:24:24 +0000" MODIFIED_BY="Sonja L  Henderson">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2009-11-09 12:29:18 +0000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Adequate sequence generation?</NAME>
<DESCRIPTION>
<P>Was the allocation sequence adequately generated?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Doi-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kilpatrick-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kilpatrick-1993">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-09 12:29:18 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yan_x002d_Rosenberg-2007">
<DESCRIPTION>
<P>Computerised programme used.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2009-11-09 12:29:19 +0000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment?</NAME>
<DESCRIPTION>
<P>Was allocation adequately concealed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-09 12:27:46 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Doi-1998">
<DESCRIPTION>
<P>Unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-09 12:28:20 +0000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kilpatrick-1991">
<DESCRIPTION>
<P>Inadequate.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-09 12:28:41 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kilpatrick-1993">
<DESCRIPTION>
<P>Unclear.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-09 12:29:19 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yan_x002d_Rosenberg-2007">
<DESCRIPTION>
<P>Sealed cards used.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2009-11-09 12:29:22 +0000" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding?</NAME>
<DESCRIPTION>
<P>Was knowledge of the allocated interventions adequately prevented during the study?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Doi-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Kilpatrick-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" RESULT="UNKNOWN" STUDY_ID="STD-Kilpatrick-1993">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-03.01" MODIFIED="2009-11-09 12:29:22 +0000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Yan_x002d_Rosenberg-2007">
<DESCRIPTION>
<P>All the infusion bags were covered by the nurse with paper bags, insuring that both the patient and the examiner were blinded to the randomisation results.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2009-11-11 10:23:57 +0000" MODIFIED_BY="Sonja L  Henderson" NO="4">
<NAME>Incomplete outcome data addressed?</NAME>
<DESCRIPTION>
<P>Were incomplete outcome data adequately addressed?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Doi-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Kilpatrick-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" RESULT="UNKNOWN" STUDY_ID="STD-Kilpatrick-1993">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2009-11-11 10:23:57 +0000" MODIFIED_BY="Sonja L  Henderson" RESULT="NO" STUDY_ID="STD-Yan_x002d_Rosenberg-2007">
<DESCRIPTION>
<P>Data were complete.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2009-11-11 10:24:21 +0000" MODIFIED_BY="Sonja L  Henderson" NO="5">
<NAME>Free of selective reporting?</NAME>
<DESCRIPTION>
<P>Are reports of the study free of suggestion of selective outcome reporting?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Doi-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kilpatrick-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kilpatrick-1993">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-11 10:24:21 +0000" MODIFIED_BY="Sonja L  Henderson" RESULT="YES" STUDY_ID="STD-Yan_x002d_Rosenberg-2007">
<DESCRIPTION>
<P>All data were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2009-11-11 10:24:24 +0000" MODIFIED_BY="Sonja L  Henderson" NO="6">
<NAME>Free of other bias?</NAME>
<DESCRIPTION>
<P>Was the study apparently free of other problems that could put it at a high risk of bias?</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Doi-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kilpatrick-1991">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY RESULT="UNKNOWN" STUDY_ID="STD-Kilpatrick-1993">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2009-11-11 10:24:24 +0000" MODIFIED_BY="Sonja L  Henderson" RESULT="YES" STUDY_ID="STD-Yan_x002d_Rosenberg-2007">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2009-11-09 12:37:16 +0000" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2009-11-09 12:33:54 +0000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Oral maternal hydration in oligohydramnios</NAME>
<CONT_OUTCOME CHI2="11.834787107350905" CI_END="2.5989247386267857" CI_START="1.426321307077056" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="2.012623022851921" ESTIMABLE="YES" I2="91.55033385113558" I2_Q="0.0" ID="CMP-001.01" NO="1" P_CHI2="5.813528026387127E-4" P_Q="1.0" P_Z="1.719490588825503E-11" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="40" TOTAL_2="38" UNITS="" WEIGHT="100.0" Z="6.728052354464917">
<NAME>Increase in amniotic fluid volume</NAME>
<GROUP_LABEL_1>Hydration</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
<CONT_DATA CI_END="4.238992152605418" CI_START="2.361007847394582" EFFECT_SIZE="3.3" ESTIMABLE="YES" MEAN_1="3.8" MEAN_2="0.5" ORDER="149" SD_1="1.9" SD_2="1.1" SE="0.47908643220593244" STUDY_ID="STD-Doi-1998" TOTAL_1="21" TOTAL_2="21" WEIGHT="38.98687312094414"/>
<CONT_DATA CI_END="1.9406016654510334" CI_START="0.4393983345489666" EFFECT_SIZE="1.19" ESTIMABLE="YES" MEAN_1="1.5" MEAN_2="0.31" ORDER="150" SD_1="1.4" SD_2="0.86" SE="0.3829670705031743" STUDY_ID="STD-Kilpatrick-1991" TOTAL_1="19" TOTAL_2="17" WEIGHT="61.013126879055854"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.030997866480448714" CI_START="-0.12900213351955142" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.08000000000000007" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.02" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.0013752208656276172" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="19" TOTAL_2="17" UNITS="" WEIGHT="100.00000000000001" Z="3.199801875986563">
<NAME>Maternal urine specific gravity (x10)</NAME>
<GROUP_LABEL_1>Hydration</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
<CONT_DATA CI_END="-0.030997866480448714" CI_START="-0.12900213351955142" EFFECT_SIZE="-0.08000000000000007" ESTIMABLE="YES" MEAN_1="10.05" MEAN_2="10.13" ORDER="151" SD_1="0.08" SD_2="0.07" SE="0.025001547939693756" STUDY_ID="STD-Kilpatrick-1991" TOTAL_1="19" TOTAL_2="17" WEIGHT="100.00000000000001"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="3" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Fetal heart rate decelerations</NAME>
<GROUP_LABEL_1>Hydration</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="4" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Maternal electrolyte disturbance</NAME>
<GROUP_LABEL_1>Hydration</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="NO" I2="0.0" I2_Q="0.0" ID="CMP-001.05" NO="5" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" UNITS="" WEIGHT="0.0" Z="0.0">
<NAME>Enrolment-delivery interval</NAME>
<GROUP_LABEL_1>Hydration</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="6" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Assisted vaginal delivery</NAME>
<GROUP_LABEL_1>Hydration</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.07" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="7" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Caesarean section</NAME>
<GROUP_LABEL_1>Hydration</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.08" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" MODIFIED="2009-11-09 12:33:54 +0000" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>5-minute Apgar score &lt; 7</NAME>
<GROUP_LABEL_1>Hydration</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.09" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="9" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Umbilical artery pH &lt; 7.2</NAME>
<GROUP_LABEL_1>Hydration</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.10" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="10" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Neonatal encephalopathy</NAME>
<GROUP_LABEL_1>Hydration</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.11" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="11" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Serious neonatal morbidity or death</NAME>
<GROUP_LABEL_1>Hydration</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.0" CI_START="0.0" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" I2_Q="0.0" ID="CMP-001.12" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" METHOD="MH" NO="12" P_CHI2="0.0" P_Q="0.0" P_Z="0.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="0" SUBGROUPS="NO" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Mother not satisfied</NAME>
<GROUP_LABEL_1>Hydration</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" NO="2">
<NAME>Oral maternal hydration in normal amniotic fluid volume</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="6.083209360919432" CI_START="2.916790639080568" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="4.5" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.01" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="2.534847493536812E-8" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="20" TOTAL_2="20" UNITS="" WEIGHT="100.00000000000001" Z="5.570860145311555">
<NAME>Increase in amniotic fluid volume</NAME>
<GROUP_LABEL_1>Hydration</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
<CONT_DATA CI_END="6.083209360919432" CI_START="2.916790639080568" EFFECT_SIZE="4.5" ESTIMABLE="YES" MEAN_1="3.0" MEAN_2="-1.5" ORDER="152" SD_1="2.4" SD_2="2.7" SE="0.8077747210701757" STUDY_ID="STD-Kilpatrick-1993" TOTAL_1="20" TOTAL_2="20" WEIGHT="100.00000000000001"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="-0.08259479553776655" CI_START="-0.17740520446223146" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.129999999999999" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-002.02" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="7.665135490171717E-8" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="20" TOTAL_2="20" UNITS="" WEIGHT="100.0" Z="5.374838498865659">
<NAME>Maternal urine specific gravity (x10)</NAME>
<GROUP_LABEL_1>Hydration</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1/>
<GRAPH_LABEL_2/>
<CONT_DATA CI_END="-0.08259479553776655" CI_START="-0.17740520446223146" EFFECT_SIZE="-0.129999999999999" ESTIMABLE="YES" MEAN_1="10.06" MEAN_2="10.19" ORDER="153" SD_1="0.06" SD_2="0.09" SE="0.02418677324489565" STUDY_ID="STD-Kilpatrick-1993" TOTAL_1="20" TOTAL_2="20" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2009-11-09 12:37:05 +0000" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Intravenous/isotonic hydration in oligohydramnios</NAME>
<CONT_OUTCOME CHI2="0.0" CI_END="0.6653438189630762" CI_START="-0.6653438189630762" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="MD" EFFECT_SIZE="0.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-003.01" MODIFIED="2009-11-09 12:37:05 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Q="1.0" P_Z="1.0" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="21" TOTAL_2="21" UNITS="" WEIGHT="100.0" Z="0.0">
<NAME>Increase in amniotic fluid volume</NAME>
<GROUP_LABEL_1>Hydration</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.6653438189630762" CI_START="-0.6653438189630762" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="0.5" MEAN_2="0.5" ORDER="154" SD_1="1.1" SD_2="1.1" SE="0.3394673699166022" STUDY_ID="STD-Doi-1998" TOTAL_1="21" TOTAL_2="21" WEIGHT="100.0"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2009-11-09 12:37:16 +0000" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Intravenous/hypotonic hydration in oligohydramnios</NAME>
<CONT_OUTCOME CHI2="10.708691374221056" CI_END="2.103735160812084" CI_START="0.6055728090140882" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="1.354653984913086" ESTIMABLE="YES" I2="90.6617908290149" I2_Q="0.0" ID="CMP-004.01" MODIFIED="2009-11-09 12:37:16 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.0010663406146672605" P_Q="1.0" P_Z="3.934485640703545E-4" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="42" TOTAL_2="44" UNITS="" WEIGHT="100.0" Z="3.544439651359375">
<NAME>Increase in amniotic fluid volume</NAME>
<GROUP_LABEL_1>Hydration</GROUP_LABEL_1>
<GROUP_LABEL_2>Control</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours treatment</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours control</GRAPH_LABEL_2>
<CONT_DATA CI_END="3.2389921526054177" CI_START="1.361007847394582" EFFECT_SIZE="2.3" ESTIMABLE="YES" MEAN_1="2.8" MEAN_2="0.5" ORDER="155" SD_1="1.9" SD_2="1.1" SE="0.47908643220593244" STUDY_ID="STD-Doi-1998" TOTAL_1="21" TOTAL_2="21" WEIGHT="63.64053788127255"/>
<CONT_DATA CI_END="0.9422819028814207" CI_START="-1.5422819028814208" EFFECT_SIZE="-0.30000000000000004" ESTIMABLE="YES" MEAN_1="1.2" MEAN_2="1.5" MODIFIED="2009-08-18 15:27:55 +0100" MODIFIED_BY="[Empty name]" ORDER="8" SD_1="2.1" SD_2="2.1" SE="0.6338289441440669" STUDY_ID="STD-Yan_x002d_Rosenberg-2007" TOTAL_1="21" TOTAL_2="23" WEIGHT="36.35946211872745"/>
</CONT_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES/>
<FEEDBACK/>
<APPENDICES MODIFIED="2009-11-09 12:34:35 +0000" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2009-11-09 12:34:35 +0000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2009-08-05 09:58:09 +0100" MODIFIED_BY="Jill V Hampson">Methods used to assess trials included in previous versions of this review</TITLE>
<APPENDIX_BODY MODIFIED="2009-11-09 12:34:35 +0000" MODIFIED_BY="[Empty name]">
<P>The following methods were used to assess <LINK REF="STD-Doi-1998" TYPE="STUDY">Doi 1998</LINK>; <LINK REF="STD-Kilpatrick-1991" TYPE="STUDY">Kilpatrick 1991</LINK>; <LINK REF="STD-Kilpatrick-1993" TYPE="STUDY">Kilpatrick 1993</LINK>.</P>
<P>Trials under consideration were evaluated for methodological quality and appropriateness for inclusion according to the prestated selection criteria, without consideration of their results. Individual outcome data were included in the analysis if they met the prestated criteria in <LINK TAG="CRIT_OUTCOMES" TYPE="SECTION">Types of outcome measures</LINK>. Included trial data were processed as described in <LINK REF="REF-Clarke-2001" TYPE="REFERENCE">Clarke 2001</LINK>.</P>
<P>Data were extracted from the sources and entered onto the Review Manager (<LINK REF="REF-RevMan-2000" TYPE="REFERENCE">RevMan 2000</LINK>) computer software, checked for accuracy, and analysed as above using the RevMan software. Continuous data were pooled using weighted mean differences and 95% confidence intervals.</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS/>
</COCHRANE_REVIEW>